| Product Code: ETC7656946 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Neurodegenerative Disease Treatment Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Neurodegenerative Disease Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Neurodegenerative Disease Treatment Market - Industry Life Cycle |
3.4 Israel Neurodegenerative Disease Treatment Market - Porter's Five Forces |
3.5 Israel Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Israel Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Drug Type:, 2021 & 2031F |
3.7 Israel Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Route of Administration:, 2021 & 2031F |
3.8 Israel Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Distribution Channel:, 2021 & 2031F |
4 Israel Neurodegenerative Disease Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurodegenerative diseases in Israel |
4.2.2 Growing awareness and focus on healthcare advancements in the country |
4.2.3 Rise in research and development activities for neurodegenerative disease treatments |
4.3 Market Restraints |
4.3.1 High cost associated with neurodegenerative disease treatments |
4.3.2 Limited access to advanced treatment options in certain regions of Israel |
4.3.3 Stringent regulatory requirements for drug approvals in the country |
5 Israel Neurodegenerative Disease Treatment Market Trends |
6 Israel Neurodegenerative Disease Treatment Market, By Types |
6.1 Israel Neurodegenerative Disease Treatment Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Israel Neurodegenerative Disease Treatment Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Israel Neurodegenerative Disease Treatment Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.1.4 Israel Neurodegenerative Disease Treatment Market Revenues & Volume, By Parkinsons Disease, 2021- 2031F |
6.1.5 Israel Neurodegenerative Disease Treatment Market Revenues & Volume, By Alzheimers Disease, 2021- 2031F |
6.1.6 Israel Neurodegenerative Disease Treatment Market Revenues & Volume, By Spinal Muscular Atrophy (SMA), 2021- 2031F |
6.1.7 Israel Neurodegenerative Disease Treatment Market Revenues & Volume, By Huntingtons Disease, 2021- 2031F |
6.1.8 Israel Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Neurodegenerative Disease Treatment Market, By Drug Type: |
6.2.1 Overview and Analysis |
6.2.2 Israel Neurodegenerative Disease Treatment Market Revenues & Volume, By N-methyl-D-aspartate Receptor Antagonists, 2021- 2031F |
6.2.3 Israel Neurodegenerative Disease Treatment Market Revenues & Volume, By Selective Serotonin Reuptake Inhibitors, 2021- 2031F |
6.2.4 Israel Neurodegenerative Disease Treatment Market Revenues & Volume, By Dopamine Inhibitors, 2021- 2031F |
6.2.5 Israel Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Neurodegenerative Disease Treatment Market, By Route of Administration: |
6.3.1 Overview and Analysis |
6.3.2 Israel Neurodegenerative Disease Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Israel Neurodegenerative Disease Treatment Market Revenues & Volume, By Injectable, 2021- 2031F |
6.3.4 Israel Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Neurodegenerative Disease Treatment Market, By Distribution Channel: |
6.4.1 Overview and Analysis |
6.4.2 Israel Neurodegenerative Disease Treatment Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Israel Neurodegenerative Disease Treatment Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 Israel Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Neurodegenerative Disease Treatment Market Import-Export Trade Statistics |
7.1 Israel Neurodegenerative Disease Treatment Market Export to Major Countries |
7.2 Israel Neurodegenerative Disease Treatment Market Imports from Major Countries |
8 Israel Neurodegenerative Disease Treatment Market Key Performance Indicators |
8.1 Number of clinical trials conducted for neurodegenerative disease treatments in Israel |
8.2 Adoption rate of innovative treatment technologies in the market |
8.3 Rate of new drug approvals for neurodegenerative diseases in Israel |
9 Israel Neurodegenerative Disease Treatment Market - Opportunity Assessment |
9.1 Israel Neurodegenerative Disease Treatment Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Israel Neurodegenerative Disease Treatment Market Opportunity Assessment, By Drug Type:, 2021 & 2031F |
9.3 Israel Neurodegenerative Disease Treatment Market Opportunity Assessment, By Route of Administration:, 2021 & 2031F |
9.4 Israel Neurodegenerative Disease Treatment Market Opportunity Assessment, By Distribution Channel:, 2021 & 2031F |
10 Israel Neurodegenerative Disease Treatment Market - Competitive Landscape |
10.1 Israel Neurodegenerative Disease Treatment Market Revenue Share, By Companies, 2024 |
10.2 Israel Neurodegenerative Disease Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here